Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Conference Call March 19, 2024 4:30 PM ET Company Participants Tim McCarthy - IR, Advisors Sergio Traversa - CEO Maged Shenouda - CFO Conference Call Participants Basma Radwan - Leerink Partners Uy Ear - Mizuho Andrew Tsai - Jefferies Andrea Tan - Goldman Sachs Operator Good afternoon, ladies and gentlemen, and welcome to the Relmada Therapeutics Inc. Fourth Quarter and Full Year 2023 Results Call. At this time, all lines are in a listen-only mode. F ...